BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9733769)

  • 1. The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis.
    Jansson M; Andersson G; Uhlén M; Nilsson B; Kördel J
    J Biol Chem; 1998 Sep; 273(38):24701-7. PubMed ID: 9733769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M; Uhlen M; Nilsson B
    Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
    Dubaquié Y; Lowman HB
    Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
    Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS
    J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
    Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
    Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
    Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.
    Abu Shehab M; Iosef C; Wildgruber R; Sardana G; Gupta MB
    Endocrinology; 2013 Mar; 154(3):1130-43. PubMed ID: 23354097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the disulfide folding pathway of insulin-like growth factor-I.
    Milner SJ; Carver JA; Ballard FJ; Francis GL
    Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.
    Shand JH; Beattie J; Song H; Phillips K; Kelly SM; Flint DJ; Allan GJ
    J Biol Chem; 2003 May; 278(20):17859-66. PubMed ID: 12626499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1.
    Skelton NJ; Chen YM; Dubree N; Quan C; Jackson DY; Cochran A; Zobel K; Deshayes K; Baca M; Pisabarro MT; Lowman HB
    Biochemistry; 2001 Jul; 40(29):8487-98. PubMed ID: 11456486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
    Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
    J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
    Hober S; Uhlén M; Nilsson B
    Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
    Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
    Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3.
    Heding A; Gill R; Ogawa Y; De Meyts P; Shymko RM
    J Biol Chem; 1996 Jun; 271(24):13948-52. PubMed ID: 8662901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.
    Bramani S; Song H; Beattie J; Tonner E; Flint DJ; Allan GJ
    J Mol Endocrinol; 1999 Aug; 23(1):117-23. PubMed ID: 10425523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
    Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
    J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
    Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
    J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
    Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
    J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3.
    Baxter RC; Bayne ML; Cascieri MA
    J Biol Chem; 1992 Jan; 267(1):60-5. PubMed ID: 1370451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.